Cartesian Therapeutics, Inc. Operating Expenses
Cartesian Therapeutics, Inc. (RNAC) reported Operating Expenses of $29.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Cartesian Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $29.16M, a 31.87% increase year-over-year.
- Cartesian Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $26.58M, a 15.61% increase year-over-year.
- Cartesian Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $79.59M, a 206.43% increase year-over-year.
- Cartesian Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $21.52M, a 19.80% increase year-over-year.
- Cartesian Therapeutics, Inc. operating expenses for fiscal 2025 was $146.20M, a 76.55% increase from fiscal 2024.
- Cartesian Therapeutics, Inc. operating expenses for fiscal 2024 was $82.81M, a 26.34% decline from fiscal 2023.
- Cartesian Therapeutics, Inc. operating expenses for fiscal 2023 was $112.42M, a 16.81% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. operating expenses for fiscal 2022 was $96.24M, a 7.32% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.16M 10-Q · filed 2026-08-06 | $55.73M 10-Q · filed 2026-08-06 | $135.32M derived: sum of 3 quarters · filed 2026-08-06 | $156.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $26.58M 10-Q · filed 2026-04-30 | $106.16M derived: sum of 2 quarters · filed 2026-04-30 | $127.68M derived: sum of 3 quarters · filed 2026-04-30 | $149.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $79.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $101.10M derived: sum of 2 quarters · filed 2026-03-09 | $123.21M derived: sum of 3 quarters · filed 2026-08-06 | $146.20M 10-K · filed 2026-03-09 |
| 2025-09-30 | $21.52M 10-Q · filed 2025-11-06 | $43.63M derived: sum of 2 quarters · filed 2026-08-06 | $66.62M 10-Q · filed 2025-11-06 | $92.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $22.11M 10-Q · filed 2026-08-06 | $45.10M 10-Q · filed 2026-08-06 | $71.07M derived: sum of 3 quarters · filed 2026-08-06 | $89.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $22.99M 10-Q · filed 2026-04-30 | $48.96M derived: sum of 2 quarters · filed 2026-04-30 | $66.92M derived: sum of 3 quarters · filed 2026-04-30 | $86.61M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $43.93M derived: sum of 2 quarters · filed 2026-03-09 | $63.62M derived: sum of 3 quarters · filed 2026-03-09 | $82.81M 10-K · filed 2026-03-09 |
| 2024-09-30 | $17.96M 10-Q · filed 2025-11-06 | $37.65M derived: sum of 2 quarters · filed 2025-11-06 | $56.84M 10-Q · filed 2025-11-06 | $101.44M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $19.69M 10-Q · filed 2025-08-07 | $38.88M 10-Q · filed 2025-08-07 | $83.47M derived: sum of 3 quarters · filed 2025-08-07 | $103.09M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $19.19M 10-Q · filed 2025-05-08 | $63.79M derived: sum of 2 quarters · filed 2025-05-08 | $83.40M derived: sum of 3 quarters · filed 2025-05-08 | $107.29M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $64.21M derived: sum of 2 quarters · filed 2025-03-13 | $88.10M derived: sum of 3 quarters · filed 2025-03-13 | $112.42M 10-K · filed 2025-03-13 |
| 2023-09-30 | $19.62M 10-Q · filed 2024-11-07 | $43.50M derived: sum of 2 quarters · filed 2024-11-07 | $67.82M 10-Q · filed 2024-11-07 | $93.11M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $23.89M 10-Q · filed 2024-08-08 | $48.21M 10-Q · filed 2024-08-08 | $73.50M derived: sum of 3 quarters · filed 2024-08-08 | $95.81M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $24.32M 10-Q · filed 2024-05-08 | $49.61M derived: sum of 2 quarters · filed 2024-05-08 | $71.92M derived: sum of 3 quarters · filed 2024-05-08 | $97.33M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $25.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $47.60M derived: sum of 2 quarters · filed 2024-03-07 | $73.01M derived: sum of 3 quarters · filed 2024-03-07 | $96.24M 10-K · filed 2024-03-07 |
| 2022-09-30 | $22.31M 10-Q · filed 2023-11-13 | $47.72M derived: sum of 2 quarters · filed 2023-11-13 | $70.95M 10-Q · filed 2023-11-13 | $96.81M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $25.41M 10-Q · filed 2023-08-17 | $48.64M 10-Q · filed 2023-08-17 | $74.50M derived: sum of 3 quarters · filed 2024-03-07 | $100.89M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $23.23M 10-Q · filed 2023-05-04 | $49.09M derived: sum of 2 quarters · filed 2024-03-07 | $75.48M derived: sum of 3 quarters · filed 2024-03-07 | $94.69M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $25.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $52.26M derived: sum of 2 quarters · filed 2024-03-07 | $71.47M derived: sum of 3 quarters · filed 2024-03-07 | $89.67M 10-K · filed 2024-03-07 |
| 2021-09-30 | $26.40M 10-Q · filed 2022-11-03 | $45.61M derived: sum of 2 quarters · filed 2022-11-03 | $63.81M 10-Q · filed 2022-11-03 | $83.66M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $19.21M 10-Q · filed 2022-08-08 | $37.42M 10-Q · filed 2022-08-08 | $57.27M derived: sum of 3 quarters · filed 2023-03-02 | $75.65M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $18.21M 10-Q · filed 2022-05-05 | $38.06M derived: sum of 2 quarters · filed 2023-03-02 | $56.44M derived: sum of 3 quarters · filed 2023-03-02 | $72.80M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $19.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $38.23M derived: sum of 2 quarters · filed 2023-03-02 | $54.60M derived: sum of 3 quarters · filed 2023-03-02 | $73.42M 10-K · filed 2023-03-02 |
| 2020-09-30 | $18.38M 10-Q · filed 2021-11-09 | $34.75M derived: sum of 2 quarters · filed 2021-11-09 | $53.57M 10-Q · filed 2021-11-09 | $72.79M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $16.37M 10-Q · filed 2021-08-12 | $35.19M 10-Q · filed 2021-08-12 | $54.41M derived: sum of 3 quarters · filed 2021-08-12 | $66.21M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $18.82M 10-Q · filed 2021-05-13 | $38.05M derived: sum of 2 quarters · filed 2021-05-13 | $49.84M derived: sum of 3 quarters · filed 2021-05-13 | $66.09M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $19.22M 10-K · filed 2020-03-12 | $31.02M derived: sum of 2 quarters · filed 2020-11-05 | $47.27M derived: sum of 3 quarters · filed 2020-11-05 | $59.13M 10-K · filed 2022-03-10 |
| 2019-09-30 | $11.79M 10-Q · filed 2020-11-05 | $28.04M derived: sum of 2 quarters · filed 2020-11-05 | $39.91M 10-Q · filed 2020-11-05 | $55.31M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $16.25M 10-Q · filed 2020-08-06 | $28.11M 10-Q · filed 2020-08-06 | $43.52M derived: sum of 3 quarters · filed 2020-08-06 | $59.46M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $11.87M 10-Q · filed 2020-05-07 | $27.27M derived: sum of 2 quarters · filed 2020-05-07 | $43.21M derived: sum of 3 quarters · filed 2020-05-07 | $61.98M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $15.40M 10-K · filed 2020-03-12 | $31.34M derived: sum of 2 quarters · filed 2020-03-12 | $50.11M derived: sum of 3 quarters · filed 2020-03-12 | $65.92M 10-K · filed 2021-03-12 |
| 2018-09-30 | $15.94M 10-K · filed 2020-03-12 | $34.71M derived: sum of 2 quarters · filed 2020-03-12 | $50.52M 10-Q · filed 2019-11-08 | $69.82M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $18.77M 10-K · filed 2020-03-12 | $34.58M 10-Q · filed 2019-08-08 | $53.88M derived: sum of 3 quarters · filed 2020-03-12 | $67.76M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $15.81M 10-K · filed 2020-03-12 | $35.11M derived: sum of 2 quarters · filed 2020-03-12 | $48.99M derived: sum of 3 quarters · filed 2020-03-12 | $64.89M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $19.29M 10-K · filed 2019-03-15 | $33.17M derived: sum of 2 quarters · filed 2019-03-15 | $49.07M derived: sum of 3 quarters · filed 2019-03-15 | $63.99M 10-K · filed 2020-03-12 |
| 2017-09-30 | $13.88M 10-K · filed 2019-03-15 | $29.78M derived: sum of 2 quarters · filed 2019-03-15 | $44.70M 10-Q · filed 2018-11-08 | $61.49M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $15.90M 10-K · filed 2019-03-15 | $30.82M 10-Q · filed 2018-08-08 | $47.61M derived: sum of 3 quarters · filed 2019-03-15 | $56.12M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $14.92M 10-K · filed 2019-03-15 | $31.71M derived: sum of 2 quarters · filed 2019-03-15 | $40.23M derived: sum of 3 quarters · filed 2019-03-15 | $48.64M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $16.79M 10-K · filed 2018-03-15 | $25.31M derived: sum of 2 quarters · filed 2018-03-15 | $33.72M derived: sum of 3 quarters · filed 2018-03-15 | $42.75M 10-K · filed 2019-03-15 |
| 2016-09-30 | $8.52M 10-K · filed 2018-03-15 | $16.93M derived: sum of 2 quarters · filed 2018-03-15 | $25.96M 10-Q · filed 2017-11-07 | $35.20M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $8.42M 10-K · filed 2018-03-15 | $17.45M 10-Q · filed 2017-08-11 | $26.69M derived: sum of 3 quarters · filed 2018-03-15 | $34.37M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $9.03M 10-K · filed 2018-03-15 | $18.27M derived: sum of 2 quarters · filed 2018-03-15 | $25.95M derived: sum of 3 quarters · filed 2018-03-15 | $33.50M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $9.24M 10-K · filed 2017-03-28 | $16.92M derived: sum of 2 quarters · filed 2017-03-28 | $24.47M derived: sum of 3 quarters · filed 2017-03-28 | $31.32M 10-K · filed 2018-03-15 |
| 2015-09-30 | $7.68M 10-K · filed 2017-03-28 | $15.23M derived: sum of 2 quarters · filed 2017-03-28 | $22.07M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $7.55M 10-K · filed 2017-03-28 | $14.40M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $6.84M 10-K · filed 2017-03-28 | |||
| 2014-12-31 | $18.44M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |